Amphotericin B injectable bulk supplier for pharma manufacturers

Amphotericin B Injectable Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) Injection

Available Strengths: 50 mg/vial, 50 mg/mL

Reference Brands: Fungizone(EU & US)

Category: Anti-fungal

Amphotericin B binds to fungal cell membrane ergosterol, creating pores that disrupt membrane integrity and cause cell death. It provides broad-spectrum antifungal activity, effective against severe systemic infections. Benefits include potent efficacy, rapid action, and availability in lipid formulations for reduced toxicity, making it essential in managing life-threatening fungal diseases. Amphotericin B injectable is available in Intravenous (IV) Injection and strengths such as 50 mg/vial, 50 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Amphotericin B injectable is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Amphotericin B injectable can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Amphotericin B is approved in the EU and US for treating severe systemic fungal infections. In the EU, brands like Fungizone (deoxycholate) and Ambisome (liposomal) are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA-approved formulations include Fungizone and AmBisome, backed by comprehensive clinical data and biosimilarity assessments. Both regions require detailed dossiers for initial approval and ongoing pharmacovigilance. For expert assistance with pharmaceutical dossiers, regulatory filings, and compliance, visit PharmaTradz. We facilitate efficient market entry for Amphotericin B formulations, ensuring adherence to European and American standards for safe, effective antifungal therapies.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Amphotericin B is used to treat severe and potentially life-threatening systemic fungal infections, including cryptococcosis, mucormycosis, aspergillosis, and systemic candidiasis. It works by binding to ergosterol in fungal cell membranes, creating pores that lead to cell death. It is often used in critically ill or immunocompromised patients.

Amphotericin B is a polyene antifungal compound derived from Streptomyces nodosus. It is formulated with suitable pharmaceutical excipients depending on the presentation, and in its conventional form it is usually complexed with deoxycholate for stability and administration.

Common trade names include Fungizone and Amphocin, used in various global markets.

Fungizone has been manufactured by Bristol-Myers Squibb. Amphocin and other versions have been produced by multiple licensed manufacturers. Many GMP-certified pharmaceutical companies also supply generic amphotericin B worldwide.

The generic name is amphotericin B.

Widely known brand names include Fungizone and Amphocin.

Amphotericin B is manufactured in several GMP-compliant facilities globally, including production sites operated by major pharmaceutical companies in the USA and Europe, as well as multiple approved manufacturers supplying generic amphotericin B to international markets.

Yes, Amphotericin B injectable is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Amphotericin B injectable is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Miltefosine

Strength:
10 mg, 50 mg

Form: Capsules

Reference Brands: Impavido (USA/EU)

View Details
Sertaconazole Nitrate

Strength:
2 %

Form: Creams

Reference Brands: Ertaczo (USA), Zalain (EU)

View Details
Econazole Nitrate

Strength:
1%

Form: Creams / Foam

Reference Brands: Ecoza (USA), Pevaryl (EU/UK) , Spectazole (USA)

View Details
Ciclopirox

Strength:
0.77%

Form: Creams/ Gel/ Lotion

Reference Brands: Loprox (USA), Penlac (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.